Assessing survival and quality of life in patients with advanced pancreatic cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates overall survival, quality of life, and resection rates in patients with borderline resectable and locally advanced pancreatic cancer across multiple Nordic hospitals. Eligibility is determined through regional multidisciplinary tumor boards, and participants will undergo assessments based on established NCCN and ISGPS guidelines. The study focuses on collecting data on exploration rates, resection rates, and overall survival outcomes for these patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Confirmed or suspected invasive pancreatic primary tumor
* Tumor classified as borderline resectable or locally advanced disease according to NCCN guidelines

Exclusion Criteria:

* Suspected endocrine tumor
* Suspected non-pancreatic periampullary tumor
* Distant metastasis
* Age \< 18 years
* Patient unable to understand verbal or written information interfering with informed consent or treatment
* Mental or organic disorder interfering with informed consent or treatments

Where it's running

• Surgical Clinic at Umeå University Hospital
  Umeå, Sweden Recruiting

Study contacts

• Study coordinator: Oskar Franklin, MD/PhD
• Email: oskar.franklin@umu.se
• Phone: +46730458558

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liquid biopsy biomarkers to detect and monitor pancreatic cancer

  Researchers test blood-based microRNA signals to see if they can identify pancreatic cancer risk or early disease in people with familial or hereditary risk or mucinous cysts.

  Recruiting Università Vita-Salute San Raffaele · Milan, MI · NCT07700992

• Predicting pancreatic fistula after pancreaticoduodenectomy

  This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.

  Recruiting Minia University · Minya · NCT07022015

• Chemotherapy sequence for pancreatic cancer treatment

  This study is testing a new order of chemotherapy drugs to see if it helps people with hard-to-treat pancreatic cancer have their tumors completely removed through surgery.

  Recruiting at 2 sites Phase 2 Wake Forest University Health Sciences · Charlotte, North Carolina and 1 other locations · NCT05825066

• Analyzing factors affecting pancreatic tumors and cysts

  This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.

  Recruiting Umeå University · Umeå · NCT05155878

• Neoadjuvant chemotherapy versus immediate surgery for resectable pancreatic head and periampullary cancer

  This trial tests if giving chemotherapy before surgery helps people with resectable pancreatic head or periampullary cancer live longer than having immediate surgery followed by chemotherapy.

  Recruiting Phase 3 Minia University · Minya, Minya Governorate · NCT07081360

• Comparing standard and prolonged chemotherapy before surgery for pancreatic cancer

  This study is testing whether giving longer chemotherapy before surgery can help people with tough-to-treat pancreatic cancer live longer and have better outcomes.

  Recruiting Phase 3 Sahlgrenska University Hospital · Gothenburg, VGR · NCT06714604

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.